Lv7
4800 积分 2024-01-26 加入
Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage
18天前
已完结
A Phase I Study of the Anti-CEACAM6 Antibody Tinurilimab (BAY 1834942) in Patients with Advanced Solid Tumors
18天前
已完结
Generation of the therapeutic monoclonal antibody NEO-201, derived from a cancer vaccine, which targets human malignancies and immune suppressor cells
19天前
已完结
Unlocking diagnostic potential: A retrospective analysis of GPNMB immunohistochemistry in nearly 1000 surgical pathology specimens
1个月前
已完结
Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study
2个月前
已完结
TrkB transmembrane domain: bridging structural understanding with therapeutic strategy
3个月前
已完结
Systemic scAAV9.U1a.hSGSH Delivery Corrects Brain Biochemistry in Mucopolysaccharidosis Type IIIA at Early and Later Stages of Disease
4个月前
已完结
Translating TRAIL-receptor targeting agents to the clinic
4个月前
已完结
Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice
5个月前
已完结
E2025, a novel anti‐EphA4 antibody, enhances EphA4 cleavage, and suppresses tau pathologies in a transgenic model of AD
9个月前
已完结
皖公网安备34019202002308
